Dyne Therapeutics Inc (DYN)
29.53
-0.46
(-1.53%)
USD |
NASDAQ |
Nov 21, 15:16
Dyne Therapeutics Price: 29.53 for Nov. 21, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 20, 2024 | 29.47 | 30.28 | 28.68 | 29.99 | 1.088M |
Nov 19, 2024 | 28.89 | 29.70 | 28.13 | 29.68 | 666665.0 |
Nov 18, 2024 | 28.28 | 29.66 | 27.04 | 29.34 | 1.268M |
Nov 15, 2024 | 30.62 | 30.62 | 27.80 | 28.39 | 1.422M |
Nov 14, 2024 | 32.54 | 33.40 | 29.78 | 30.31 | 1.443M |
Nov 13, 2024 | 29.12 | 35.68 | 29.02 | 34.13 | 2.236M |
Nov 12, 2024 | 28.04 | 31.38 | 27.99 | 29.33 | 1.925M |
Nov 11, 2024 | 29.01 | 29.74 | 28.10 | 28.13 | 999465.0 |
Nov 08, 2024 | 29.29 | 29.55 | 28.13 | 28.48 | 1.262M |
Nov 07, 2024 | 29.86 | 30.97 | 29.20 | 29.27 | 787483.0 |
Nov 06, 2024 | 29.92 | 30.43 | 29.31 | 29.81 | 1.030M |
Nov 05, 2024 | 28.70 | 29.00 | 28.25 | 28.62 | 845096.0 |
Nov 04, 2024 | 28.01 | 29.20 | 27.92 | 28.78 | 1.081M |
Nov 01, 2024 | 29.09 | 29.22 | 27.66 | 28.74 | 961896.0 |
Oct 31, 2024 | 29.09 | 29.21 | 28.22 | 28.86 | 1.029M |
Oct 30, 2024 | 29.98 | 30.61 | 28.99 | 29.20 | 712713.0 |
Oct 29, 2024 | 30.67 | 30.67 | 29.94 | 30.22 | 716830.0 |
Oct 28, 2024 | 31.49 | 31.55 | 30.65 | 30.78 | 796008.0 |
Oct 25, 2024 | 31.22 | 31.83 | 30.67 | 30.73 | 802932.0 |
Oct 24, 2024 | 31.33 | 32.25 | 30.69 | 31.10 | 972564.0 |
Oct 23, 2024 | 33.16 | 33.42 | 32.00 | 32.36 | 781579.0 |
Oct 22, 2024 | 32.81 | 33.69 | 32.79 | 33.39 | 243743.0 |
Oct 21, 2024 | 34.82 | 35.00 | 33.44 | 33.48 | 709440.0 |
Oct 18, 2024 | 34.92 | 35.40 | 34.49 | 35.24 | 1.597M |
Oct 17, 2024 | 35.41 | 35.77 | 34.70 | 34.73 | 689029.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
4.36
Minimum
Jun 02 2022
47.04
Maximum
Aug 21 2024
17.17
Average
14.37
Median
Oct 21 2021
Price Benchmarks
Sarepta Therapeutics Inc | 110.30 |
Capricor Therapeutics Inc | 18.16 |
Regenxbio Inc | 9.18 |
Catalyst Pharmaceuticals Inc | 20.98 |
Novavax Inc | 8.14 |
Price Related Metrics
Price to Book Value | 4.259 |
Earnings Yield | -12.06% |
Market Cap | 3.005B |